CoChat

Economic and humanistic burden associated with depression and anxiety among adults with non‐communicable chronic diseases (NCCDs) in the United States

Open access

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Patients with both major depressive disorder (MDD) and generalized anxiety disorder (GAD) in addition to one or multiple comorbid non-communicable chronic diseases (NCCDs) face unique challenges. However, few studies have characterized how the burden of co-occurring MDD and GAD differs from that of only MDD or only GAD among patients with NCCDs. METHODS: In this study, we used Medical Expenditures Panel Survey data from 2010-2017 to understand how the economic and humanistic burden of co-occurring MDD and GAD differs from that of MDD or GAD alone among patients with NCCDs. We used generalized linear models to investigate this relationship and controlled for patient sociodemographics and clinical characteristics. RESULTS: Co-occurring MDD and GAD was associated with increases in mean annual per patient inpatient visits, office visits, emergency department visits, annual drug costs, and total medical costs. Among patients with 3+ NCCDs, MDD or GAD only was associated with lower odds ratios (ORs) of limitations in activities of daily living (ADLs; 0.532 and 0.508, respectively) and social (0.503, 0.526) and physical limitations (0.613, 0.613) compared to co-occurring MDD and GAD. Compared to patients with co-occurring MDD and GAD, having MDD only or GAD only was associated with significantly lower odds of cognitive limitations (0.659 and 0.461, respectively) in patients with 1-2 NCCDs and patients with 3+ NCCDs (0.511, 0.416). DISCUSSION: Comorbid MDD and GAD was associated with higher economic burden, lower quality of life, and greater limitations in daily living compared to MDD or GAD alone. Health-related economic and humanistic burden increased with number of NCCDs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/jmdh.s280200

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Patient flow chart. aBipolar disorder, adjustment disorder, personality disorder, schizophrenia and psychotic disorders, substance-related disorders, delirium, dementia, amnestic disorders (including Alzheimer’s disease), and Parkinson’s disease.
Figure 1 Patient flow chart. aBipolar disorder, adjustment disorder, personality disorder, schizophrenia and psychotic disorders, substance-related disorders, delirium, dementia, amnestic disorders (including Alzheimer’s disease), and Parkinson’s disease.CC BY-NC · PubMed Central
Figure 2 Adjusted (A) per patient per year total medical costs (2018 US dollars), (B) mean SF-12v2 MCS scores, (C) mean SF-12v2 PCS scores, and (D) mean EQ-5D scores associated with the number of NCCDs among patients with MDD only, GAD only, and co-occurring MDD and GAD. *Denotes statistically significant (P ≤.05) results relative to the reference value. For all adjusted analyses the reference value was comorbid MDD and GAD.
Figure 2 Adjusted (A) per patient per year total medical costs (2018 US dollars), (B) mean SF-12v2 MCS scores, (C) mean SF-12v2 PCS scores, and (D) mean EQ-5D scores associated with the number of NCCDs among patients with MDD only, GAD only, and co-occurring MDD and GAD. *Denotes statistically significant (P ≤.05) results relative to the reference value. For all adjusted analyses the reference value was comorbid MDD and GAD.CC BY-NC · PubMed Central
Figure 3 Adjusted odds ratios (95% CIs) associated with the number of NCCDs for (A) limitations in ADLs, (B) cognitive limitations, (C) physical limitations, and (D) social limitations among patients with MDD only, GAD only, and co-occurring MDD and GAD.
Figure 3 Adjusted odds ratios (95% CIs) associated with the number of NCCDs for (A) limitations in ADLs, (B) cognitive limitations, (C) physical limitations, and (D) social limitations among patients with MDD only, GAD only, and co-occurring MDD and GAD.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 3

  1. 2005, Computing Standard Errors for MEPS Estimates
  2. 2009, Year Book of Psychiatry & Applied Mental Health
  3. Melek S, Norris D Chronic conditions and comorbid psychological disorders. Paper presented at: Journal Of Mental Health Policy And Economics; 2011.

Cited by

See all 24

Metadata

Authors
Armbrecht, E., Shah, R., Poorman, G. W., Luo, L., Stephens, J. M., Li, B., Pappadopulos, E., Haider, S., & McIntyre, R. S.
Affiliations
  • Saint Louis University (US)
  • Pharmerit (United States) (US)
  • Pfizer (United States) (US)
  • Viatris (US)
  • University Health Network (CA)
Corresponding author
Stephens, Jennifer M
Venue
Journal of Multidisciplinary Healthcare
Published
2021-04
Volume
Volume 14
Pages
887-896
ISSN
1178-2390 (ISSN-L)
OpenAlex
W3156276376
Cited by
24
References
27
Citations by year
2026: 4 · 2025: 7 · 2024: 4 · 2023: 6 · 2022: 2 · 2021: 1
FWCI
3.18
Type
journal article
Language
en
Open access
Locations
  • Journal of Multidisciplinary Healthcare (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
Pfizer
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
Keywords
major depressive disorder, generalized anxiety disorder, comorbidities, non-communicable diseases, economic burden, humanistic burden, quality of life, activities of daily living, health care costs, health care utilization, cognitive limitations, polypharmacy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.